Should prophylaxis for Pneumocystis carinii pneumonia in solid organ transplant recipients ever be discontinued?

Clinical Infectious Diseases

Volumn 28, Issue 2, 1999, Pages 240-249

  Gordon, Steven M ^a   LaRosa, Steven P ^a,b   Kalmadi, Sujith ^a   Arroliga, Alejandro C ^a   Avery, Robin K ^a   Truesdell LaRosa, Laura ^a   Longworth, David L ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; PREDNISONE; SULFAMETHOXAZOLE; TRIMETHOPRIM;

ADULT; ALLERGY; ARTICLE; CLINICAL ARTICLE; COST BENEFIT ANALYSIS; DISEASE ASSOCIATION; FEMALE; HIGH RISK POPULATION; HUMAN; MALE; MORBIDITY; ORGAN TRANSPLANTATION; PNEUMOCYSTIS PNEUMONIA; PRIMARY PREVENTION; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0033010003     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/515126     Document Type: Article

References (46)

1. 1. Fishman JA. Pneumocystis carinii and parasitic infection in transplantation. Infect Dis Clin North Am 1995;9:1005-44.
2. 2. Sepkowitz KA, Brown AE, Armstrong D. Pneumocystis carinii pneumonia without acquired immunodeficiency syndrome. Arch Intern Med 1995;155:1125-8.
3. 3. Yale SH, Limper AH. Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illnesses and prior corticosteroid therapy. Mayo Clin Proc 1996;71:5-13.
4. 4. Walzer PD, Perl DP, Krogstad DJ, et al. Pneumocystis carinii pneumonia in the United States. Ann Intern Med 1974;80:83-93.
5. 5. Arend SM, Kroon FP, Van't Wout JW. Pneumocystis carinii pneumonia in patients without AIDS, 1980 through 1993. Arch Intern Med 1995;155:2436-41.
6. 6. Peters SG, Prakash UBS. Pneumocystis carinii pneumonia. Am J Med 1987;82:73-8.
7. 7. Sepkowitz KA, Brown ARE, Telzak EE, et al. Pneumocystis carinii pneumonia among patients without AIDS at a cancer hospital. JAMA 1992;267:832-7.
8. 8. Olsen SL, Renlund DG, O'Connell JB, et al. Prevention of Pneumocystis carinii pneumonia in cardiac transplant recipients by trimethoprim-sulfamethoxazole. Transplantation 1993;56:359-62.
9. 9. Centers for Disease Control and Prevention. 1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. MMWR Morb Mortal Wkly Rep 1997;46(RR-12):4-7.
10. 10. Rubin RH. Infection in the organ transplant recipient. In: Rubin R, Young L, eds. Clinical approach to infection in the compromised host. 3rd ed. New York: Plenum Medical Book Company, 1994.
11. 11. Dean A. Epi-info software, version 6.02. Atlanta: Centers for Disease Control and Prevention, 1994.
12. 12. Gryzan S, Paradis IL, Zeev A, et al. Unexpectedly high incidence of Pneumocystis carinii infection after lung-heart transplantation. Am Rev Respir Dis 1988;137:1268-74.
13. 13. Dummer JS, Montero CG, Griffith BP, et al. Infections in heart-lung transplant recipients. Transplantation 1986;41:725-9.
14. 14. Kramer M, Stoehr C, Lewiston NJ, et al. Trimethoprim-sulfamethoxazole prophylaxis for Pneumocystis carinii infections in heart-lung and lung transplantation - how effective and for how long? Transplantation 1992;53:586-9.
15. 15. Penketh ARL, Higenbottam TW, Hutter J, et al. Clinical experience in the management of pulmonary opportunist infection and rejection in recipients of heart-lung transplants. Thorax 1988;43:762-9.
16. 16. Narrins B, Jessup M. Pneumocystis carinii pneumonia after heart transplantation: a growing problem [abstract no 51]. J Heart Lung Transplant 1990;9:67.
17. 17. Hofflin JM, Potasman I, Baldwin JC, et al. Infectious complications in heart transplant recipients receiving cyclosporine and corticosteroids. Ann Intern Med 1987;106:209-16.
18. 18. Grossi P, Ippoliti GB, Coggi C, et al. Pneumocystis carinii pneumonia in heart transplant recipients. Infection 1993;21:75-9.
19. 19. Munoz P, Rosa M, Paloma J, et al. Pneumocystis carinii infection in heart transplant recipients. Medicine (Baltimore) 1997;76:415-22.
20. 20. Cooper DKC, Lanza RP, Oliver S, et al. Infectious complications after heart transplantation. Thorax 1983;38:822-8.
21. 21. Schafers HJ, Cremer J, Wahlers T, et al. Pneumocystis carinii pneumonia following heart transplantation. Eur J Cardiothorac Surg 1987;1: 49-52.
22. 22. Colombo JL, Sammut PH, Langas AN, Shaw BW. The spectrum of Pneumocytis carinii infection after liver transplantation in children. Transplantation 1992;54:621-4.
23. 23. Paya CV, Hermans PE, Washington JA, Smith T, Anhalt JP, Krom RA. Incidence, distribution, and outcome of episodes of infection in 100 orthotopic liver transplantations. Mayo Clin Proc 1989;64:555-64.
24. 24. Kusne S, Dummer JS, Singh N, et al. Infections after liver transplantation: an analysis of 101 consecutive cases. Medicine (Baltimore) 1988;67: 132-43.
25. 25. Hardy AM, Wajszcuk CP, Suffrendini AF, Hakala TR, Ho M. Pneumocystis carinii pneumonia in renal-transplant recipients treated with cyclosporine and steroids. J Infect Dis 1984;149:143-7.
26. 26. Santiago-Dephin EA, Mora E, Gonzalez AZ, Morales-Otero LA, Bermudez R. Factors in an outbreak of Pneumocystis carinii in a transplant unit. Transplant Proc 1988;20:462-5.
27. 27. Talseth T, Holdaas H, Albrechtsen D, et al. Increasing incidence of Pneumocystis carinii pneumonia in renal transplant patients. Transplant Proc 1988;20:400-1.
28. 28. Bourbigot B, Bensoussan T, Garo B, et al. CD4 T-lymphocytes as predictors of pneumonia after kidney transplantation. Transplant Proc 1993;25:1491-2.
29. 29. Sugimoto H, Uchida H, Akiyama T, et al. Improved survival of renal allograft recipients with Pneumocystis carinii pneumonia by early diagnosis and treatment. Transplant Proc 1992;24:1556-8.
30. 30. Higgins RM, Bloom SL, Hopkin JM, Morris PJ. The risks and benefits of low-dose cotrimoxazole prophylaxis for Pneumocystis pneumonia in renal transplantation. Transplantation 1989;47:558-60.
31. 31. Johnson PC, Lewis RM, Van Buren CT, Kahan BD. Pneumocystis carinii pneumonia in renal transplant recipients [letter]. Arch Surg 1988;123: 912-3.
32. 32. Jarwenko M, Pifer L, Kerman R, et al. Serologic methods for the early diagnosis of Pneumocystis carinii infection in renal allograft recipients. Transplantation 1986;41:436-42.
33. 33. Fox BC, Sollinger HW, Belzer FO, Maki DG. A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation: clinical efficacy, absorption of trimethoprim-sulfamethoxazole, effects on the micro flora, and the cost-benefit of prophylaxis. Am J Med 1990;89:255-74.
34. 34. Ellinder C-G, Andersson J, Bolinder G, Tyden G. Effectiveness of low-dose cotrimoxazole prophylaxis against Pneumocystis carinii pneumonia after renal and/or pancreas transplantation. Transplant Int 1992;5:81-4.
35. 35. Arend SM, Westendorp RGJ, Kroon FP, et al. Rejection treatment and cytomegalovirus infection as risk factors for Pneumocystis carinii pneumonia in renal transplant recipients. Clin Infect Dis 1996;22: 920-5.
36. 36. Zaman MK, White DA. Serum lactate dehydrogenase levels and Pneumocystis carinii pneumonia. Am Rev Respir Dis 1988;137:796-800.
37. 37. Keely SP, Stringer JR, Baughman RP, et al. Genetic variation among Pneumocystis carinii hominis in recurrent pneumocystosis. J Infect Dis 1995;172:595-8.
38. 38. Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med 1998;338:1741-51.
39. 39. Feder HM, Milch LR. Viral load and combination therapy for human immunodeficiency virus [letter]. N Engl J Med 1997;336:959-60.
40. 40. Wells CL, Podzorski RP, Peterson PK, et al. Incidence of trimethoprim-sulfamethoxazole-resistant Enterobacteriaceae among transplant recipients. J Infect Dis 1984;150:699-706.
41. 41. Murray BE, Rensimer ER, Dupont HL. Emergence of high level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim-sulfamethoxazole. N Engl J Med 1982;306:130-5.
42. 42. Tolkoff-Rubin NE, Cosimi AB, Russell PS, Rubin RH. A controlled study of trimethoprim-sulfamethoxazole prophylaxis of urinary tract infections in renal transplant recipients. Rev Infect Dis 1982;4:614-8.
43. 43. Thompson JF, Chalmers DHK, Hunnisett AGW, Wood RFM, Morris PJ. Nephrotoxicity of trimethoprim and cotrimoxazole in renal allograft recipients treated with cyclosporine. Transplantation 1983;36:203-6.
44. 44. Maki DG, Fox BC, Kuntz J, Sollinger HW, Belzer FO. A prospective randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation. Side effects of trimethoprim-sulfamethoxazole, interaction with cyclosporine. J Lab Clin Med 1992;119:11-24.
45. 45. Rubin RH. Impact of cytomegalovirus infection on organ transplant recipients. Rev Infect Dis 1990;12:S754-67.
46. 46. Hibberd PL, Rubin RH. Clinical aspects of fungal infection in organ transplant recipients. Clin Infect Dis 1994;19(suppl 1):S33-40.